322 cases · page 7 of 11
Showing 181–209Qualcomm Incorporated v.Respondent
Qualcomm Incorporated filed a patent infringement action on 17 July 2024 before the Local Division Munich against six defendants concerning European patent EP 2 286 325. After reaching a settlement with Defendant 1 (Shenzhen Transsion Holdings), Qualcomm withdrew the action on 17 January 2025 and applied for a 60% reimbursement of court fees. The Court permitted the withdrawal, declared the proceedings closed, and ordered reimbursement of €18,600.00 to the Claimant.
Fuchs Patentanwälte Partnerschaft mbB v.Respondent
This is an order from the Local Chamber Munich concerning European Patent No. 1 838 002, in which patent attorney Christian Läufer requested access to court filings and evidence under Rule 262.1(b) of the Rules of Procedure as a member of the public for learning and training purposes. Neither the plaintiff (Avago Technologies) nor the defendants (Tesla Germany GmbH and Tesla Manufacturing Brandenburg SE) raised objections to the request. The presiding judge granted the applicant access to the filings and annexes in the counterclaim for revocation workflow, but not to the infringement proceedings file or other workflows.
SnowPixie Co., Ltd. v.Respondent
This order concerns an application by the defendant in infringement proceedings for the Local Chamber Munich to order the plaintiff to provide security for costs under Rule 158 of the Rules of Procedure of the Unified Patent Court. The applicant argued that the plaintiff, a small enterprise, lacked sufficient financial means, citing a low credit rating and recent operating losses. The court ordered security for costs but reduced the amount based on equity considerations, while rejecting the plaintiff's application for legal aid because it was capable of bearing both its own costs and the ordered security.
Lenovo (Singapore) Pte. Ltd. v.ASUSTek Computer Inc., ASUS Computer GmbH, ASUSTEK (UK) LIMITED
This is a procedural order issued by the Local Chamber Munich in an infringement action concerning European Patent No. 3 682 587. The plaintiff Lenovo (Singapore) Pte. Ltd. brought the action against three ASUS entities. The presiding judge scheduled an interim hearing via video conference for September 25, 2025, and an oral hearing in person for November 19, 2025, in Munich, with deadlines for parties to submit proposed topics and cost estimates.
Snowpixie Co., Ltd. v.Golf Tech Golfartikel Vertriebs GmbH
The defendant in an underlying patent infringement proceeding applied for an order requiring the plaintiff to provide security for costs under Rule 158 of the Rules of Procedure, citing the plaintiff's poor credit rating and recent operating losses. The plaintiff opposed the application and alternatively sought legal aid. The Local Chamber Munich ordered the plaintiff to provide security in a reduced amount, finding that although the plaintiff qualified as a small enterprise with insufficient assets, equity considerations and the principle of effective access to justice warranted a reduction below the applicant's requested EUR 257,000. Legal aid was denied because the plaintiff was capable of bearing both its own costs and the reduced security.
Zentiva France, Zentiva, k.s., Zentiva Pharma GmbH v.Sanofi Mature IP
This is a procedural order issued by the Local Division Munich of the Unified Patent Court scheduling an interim conference and oral hearing in consolidated infringement actions concerning European Patent No. 2 493 466. The claimants are multiple Sanofi entities, and the defendants include Zentiva France, Zentiva Pharma GmbH, and Zentiva, k.s. (among other defendants in related proceedings). The Presiding Judge set the interim conference for 17 July 2025 and the oral hearing for 14-17 October 2025.
TCL Deutschland GmbH & Co. KG, TCL Operations Polska Sp. z.o.o, TCT Mobile Germany GmbH, TCT Mobile Europe SAS v.Respondent
The Local Division Munich of the Unified Patent Court addressed the withdrawal of counterclaims for revocation and for a FRAND-license offer filed by certain TCL defendants in a patent infringement action brought by NEC Corporation concerning European patent EP 2 645 714. Following a settlement and the conclusion of a patent licence agreement, the defendants withdrew both counterclaims and sought partial reimbursement of court fees. The court permitted the withdrawals, ordered 60% reimbursement of court fees for both counterclaims, and held that a counterclaim for a FRAND-license offer is subject to court fees by analogous application of Rule 370 RoP.
Headwater Research LLC v.Respondent
This is a procedural order from the Local Division Munich of the Court of First Instance concerning European Patent EP 2 391 947. The order addresses multiple applications including Samsung's filing on Headwater's standing to sue, Samsung's confidentiality application, and Headwater's applications for leave to amend its pleadings. The Court granted Headwater leave to amend its claims, dismissed Samsung's confidentiality application as superfluous, and set deadlines for further submissions and the Interim Conference.
Heraeus Electronics GmbH & Co. KG v.Vibrantz GmbH
This is a procedural order issued by the Local Division Munich in an infringement action concerning European Patent No. 3 215 288. The order reschedules the interim hearing (Zwischenanhörung) from May 23, 2025 to May 28, 2025 due to a scheduling conflict, while confirming the oral hearing date of July 1, 2025. The written proceedings are set to close on May 14, 2025, and parties may submit substantive proposals for the interim hearing until May 23, 2025.
Meril Life Sciences Pvt Ltd., Meril Gmbh v.Respondent
This is an order from the Local Division Munich of the Unified Patent Court concerning EP 3 646 825, dealing with procedural applications following a prior infringement decision. Meril (the defendants) sought an extension of the deadline to comment on Edwards Lifesciences' application for a cost decision, arguing that pending confidentiality issues prevented them from properly responding. The judge-rapporteur lifted all deadlines relating to the cost decision and the protection of confidential information, with new deadlines to be set in due course.
Edwards Lifesciences Corporation v.Meril Gmbh, Meril Life Sciences Pvt Ltd.
This order from the Local Division Munich of the Unified Patent Court concerns European patent EP 3 646 825 and addresses procedural matters related to Edwards's application for a cost decision and competing confidentiality applications under Rule 262A RoP. The court indicated its intention to follow the reasoning of the Central Division (Paris Seat) order of 30 July 2024, which would grant Meril unlimited access to the costs application while restricting third-party/public access under Rule 262.2 RoP. Edwards was invited to comment within 10 days on the confidentiality applications before the court would invite Meril to comment on the costs application.
Meril Gmbh, Meril Life Sciences Pvt Ltd. v.Respondent
Before the Local Division Munich concerning EP 3 646 825, Meril sought a partial stay of proceedings relating to Edwards Lifesciences' cost decision application and a stay of the confidentiality information application, pending a Court of Appeal decision. The judge-rapporteur indicated willingness to order a full stay if both parties agreed, but neither party requested one. Meril then informed the court that its confidentiality stay application would not be maintained if a full or partial stay of the costs proceedings was not granted, rendering a decision on that application unnecessary.
Sanofi Winthrop Industrie, Sanofi S.r.l., Sanofi B.V., Sanofi AB, Sanofi-Aventis GmbH, Sanofi-Aventis Deutschland GmbH, Sanofi Mature IP, Sanofi Belgium, Sanofi A/S, Sanofi - Produtos Farmaceuticos Lda v.Accord Healthcare AB, Accord Healthcare S.L.U., Accord Healthcare GmbH, Accord Healthcare Italia Srl, Accord Healthcare BV, Accord Healthcare B.V., Accord Healthcare, Unipessoal Lda.
This is a procedural order from the Local Division Munich of the Unified Patent Court issued on 22 January 2025, consolidating four parallel patent infringement actions (UPC_CFI_145/2024 through UPC_CFI_148/2024) brought by multiple Sanofi entities against Accord Healthcare, STADA, Reddy Pharma, and Zentiva regarding European Patent No. 2 493 466. The defendants raised preliminary objections concerning jurisdiction, standing of certain claimants, and the scope of the claims. Following a preliminary interim conference, the court ordered Sanofi to remedy deficiencies in its formal submissions within 7 days, invited defendants to comment within 14 days, waived all other deadlines, and set the values of the infringement claims and counterclaims.
air up group GmbH v.Respondent
This case before the Local Division Munich concerned the service of a decision by default in provisional measures proceedings regarding European Patent EP 3 655 341. The defendant, domiciled in China, could not be served through the Chinese authorities under the Hague Service Convention, which failed to process service for over six months. The court held that publication of the decision by default on the Court's website, with notification to the defendant by email, constitutes good service pursuant to Rule 275.2 of the Rules of Procedure.
XSYS Italia S.r.l., XSYS Germany GmbH, XSYS Prepress N.V. v.Respondent
ORDER of the President of the Court of First Instance in the proceedings before the Local Division MUNICH pursuant to R. 323 RoP (language of the proceedings) issued on 15/01/2025 APPLICANTS (DEFENDANTS IN THE MAIN PROCEEDINGS): 1) XSYS Germany GmbH, Industriestraße 1, 77731 Willstätt - G
NEC Corporation v.Respondent
NEC Corporation filed a patent infringement action against multiple TCL entities concerning European patent EP 2 645 714 before the Local Division Munich. Before the closure of the written procedure, the parties reached a contractual agreement, and NEC declared withdrawal of the action. The Court permitted the withdrawal, declared the proceedings closed, and ordered reimbursement of 60% of the court fees paid by NEC.
Sanofi-Aventis Deutschland GmbH, Sanofi Winthrop Industrie, Sanofi - Produtos Farmaceuticos Lda, Sanofi Belgium, Sanofi S.r.l., Sanofi B.V., Sanofi A/S, Sanofi AB, Sanofi Mature IP, Sanofi-Aventis GmbH v.Respondent
This is a procedural order from the Local Division Munich of the Unified Patent Court concerning four related patent infringement actions involving European Patent No. 2 493 466. The claimants, a group of Sanofi entities, sought substitution of Sanofi Mature IP by Sanofi SA following a corporate reorganization in which Sanofi Mature IP was dissolved without liquidation and its assets, including the patent in suit, were universally transferred to Sanofi SA. The defendants raised no objections at the preliminary interim conference, and the Court granted the substitution, holding that it had no consequence on the proceedings under Rules 306 and 310 RoP.
NVIDIA Corporation, NVIDIA GmbH v.Respondent
This is a procedural order by the President of the Court of First Instance concerning an application by NVIDIA Corporation and NVIDIA GmbH (Defendants in the main infringement proceedings) to change the language of proceedings from German to English under R. 323 RoP and Article 49(5) UPCA. The main infringement action was brought by BF exaQC AG and ParTec AG based on European patents EP3743812 and EP2628080, both granted in English. NVIDIA argued that English should be adopted as the language of proceedings because it is the language of the patents, while the Claimants opposed the change. The order sets out the parties' positions and the points at issue for the court's consideration.
Abbott Diabetes Care Inc. v.Respondent
Abbott Diabetes Care Inc. filed a patent infringement action against Dexcom entities concerning European patent EP 4 087 195 before the Local Division Munich. Following the filing of counterclaims for revocation by the defendants and an application to amend the patent by the claimant, all parties mutually withdrew their respective claims before the scheduled oral hearing. The Court permitted the withdrawals, declared the proceedings closed, and ordered each party to bear its own extrajudicial costs with no reimbursement between the parties.
Accord Healthcare GmbH, Accord Healthcare, Unipessoal Lda., Accord Healthcare BV, Accord Healthcare Italia Srl, Accord Healthcare B.V., Accord Healthcare AB, Accord Healthcare S.L.U. v.Sanofi B.V., Sanofi-Aventis GmbH, Sanofi Mature IP, Sanofi Winthrop Industrie, Sanofi S.r.l., Sanofi-Aventis Deutschland GmbH, Sanofi - Produtos Farmaceuticos Lda, Sanofi AB, Sanofi A/S, Sanofi Belgium
This procedural order from the Local Division Munich of the Unified Patent Court concerns four consolidated patent infringement actions involving European Patent No. 2 493 466 (relating to cabazitaxel). The dispute centered on access to confidential information contained in Claimants' Exhibit No. D.4 (a witness statement with appendices). The court granted partial confidentiality protection while expanding access beyond Sanofi's requested limitation to only the named UPC representatives, allowing access to specified legal teams and at least one natural person from each Defendant group.
President and Fellows of Harvard College v.Respondent
This Revised Order concerns procedural matters in a patent infringement action before the Local Division Munich. The dispute centers on Claimant 2 (Harvard College)'s filing of 55 auxiliary requests in its application to amend the patent at issue, with parallel opposition proceedings pending before the European Patent Office (EPO). The Defendants sought to limit the number of auxiliary requests and adjust procedural deadlines, while the judge-rapporteur had previously ordered a stay of proceedings and a reduction of auxiliary requests to a one-digit number. The Revised Order addresses Claimant 2's subsequent application regarding the implementation of these prior orders.
Edwards Lifesciences Corporation v.Meril GmbH, Meril Life Sciences Pvt Ltd.
This cost determination proceedings order concerned the reimbursement of costs from prior interim injunction proceedings between Edwards Lifesciences Corporation and Meril GmbH and Meril Life Sciences Pvt. Ltd. The parties had agreed on the principal amounts of recoverable costs, but Edwards sought additional interest at five percentage points above the base rate under § 247 BGB from the date of filing. The court rejected the interest claim, holding that reimbursable procedural costs and expenses do not bear interest in cost determination proceedings.
Netgear Deutschland GmbH, Netgear International Limited, Netgear Inc. v.Respondent
This procedural order concerns an application by the Netgear group of companies to withdraw their action for a declaration of non-infringement against Huawei Technologies Co. Ltd regarding European Patent Nos. 3 678 321 and EP 3 611 989. The defendant had already consented to the withdrawal in parallel proceedings. The court granted the withdrawal, terminated the proceedings, set the dispute value at €1 million, and ordered reimbursement of 40% of the court fees paid, with each party bearing their own costs.
Huawei Technologies Co. Ltd v.Respondent
This case concerned an infringement action filed by Huawei Technologies Co. Ltd against three Netgear entities regarding European Patent No. 3 678 321, accompanied by a counterclaim for revocation. Both parties reached a settlement and jointly applied for leave to withdraw their respective claims. The court granted the withdrawal, terminated the proceedings, and ordered a 40% refund of the court fees paid by each party, with each side bearing its own costs.
UPC Decision UPC-001054 v.Respondent
The Local Division Munich issued a decision by default against Guangzhou Aiyun Yanwu Technology Co., Ltd. for infringement of EP 3 897 305, a patent protecting a drinking device for retronasal perception of aroma substances. The defendant, a Chinese company, failed to respond to the application served under Rule 275.2 RoP. The court found the patent valid and infringed, ordering the defendant to cease infringing activities across UPC Member States, pay penalties of up to EUR 100,000 per day of infringement, and bear the costs of proceedings.
UPC Decision UPC-001047 v.Respondent
The Local Division Munich of the Unified Patent Court issued a decision by default against Guangzhou Aiyun Yanwu Technology Co., Ltd. for infringing EP 3 655 341, owned by air up group GmbH, which protects a drinking device for retronasal reception of an aroma substance. The defendant, a Chinese company selling a competing drinking bottle with aroma pods, failed to respond to the application served under Rule 275.2 RoP. The court ordered the defendant to cease and desist from the infringing activities across UPC Member States, imposed a penalty of up to EUR 100,000 per day of infringement, and ordered the defendant to pay the costs of the proceedings.
Dyson Technology Limited v.Respondent
This is a procedural order issued by the Local Chamber Munich concerning European Patent No. 2 043 492. Dyson Technology Limited, as plaintiff, requested the suspension of both the infringement proceedings and the related counterclaim proceedings, submitting the defendants' written consent dated January 3, 2025. The presiding judge granted the request, ordering the suspension of both proceedings and cancelling the scheduled interim hearing of May 8, 2025 and main hearing of June 3, 2025.
Sanofi - Produtos Farmaceuticos Lda, Sanofi B.V., Sanofi Mature IP, Sanofi Winthrop Industrie, Sanofi A/S, Sanofi Belgium, Sanofi-Aventis Deutschland GmbH, Sanofi S.r.l., Sanofi-Aventis France, Sanofi AB, Sanofi-Aventis GmbH v.Respondent
This procedural order concerns four related patent infringement actions brought by multiple Sanofi entities against Accord Healthcare, STADA, Reddy Pharma, and Zentiva regarding European Patent No. 2 493 466. The core issue was Sanofi's application under Rule 305 RoP to substitute Sanofi-Aventis France with Sanofi Winthrop Industrie following a corporate merger. The court granted the substitution, ruling that the retroactive effect of the merger was not relevant and that no formal stay of proceedings was necessary.
Avago Technologies International Sales Pte. Limited. v.Respondent
Avago Technologies International Sales Pte. Limited filed an infringement action against Tesla Germany GmbH and Tesla Manufacturing Brandenburg SE concerning European Patent EP 1 770 912 B1. The defendants had filed a counterclaim for invalidity. Before any decision on the merits, the plaintiff withdrew the infringement action, and the defendants consented to the withdrawal. The Local Chamber Munich permitted the withdrawal, terminated the proceedings, and ordered each party to bear its own costs.
Huawei Technologies Co. Ltd v.Netgear International Limited, NETGEAR Deutschland GmbH, Netgear Inc.
This is a procedural order from the Local Chamber Munich concerning European Patent No. 3 678 321. Huawei Technologies Co. Ltd filed an infringement action against three Netgear entities, who filed a counterclaim for invalidity. Both parties agreed to have the infringement action and the invalidity counterclaim heard together before the Local Chamber Munich, and the panel concurred with this request.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.